Brief: Orchestra BiomMed Says Expected Operating Cash Runway Sufficient Into 2H 2026, Beyond Anticipated Backbeat Top-Line Results Readout, Based On Internal Forecast
Nov 13 (Reuters) - Orchestra BioMed Holdings Inc
OBIO.O :
* ORCHESTRA BIOMED:EXPECTED OPERATING CASH RUNWAY SUFFICIENT
INTO
2H 2026, BEYOND ANTICIPATED BACKBEAT TOP-LINE RESULTS READOUT,
BASED ON INTERNAL FORECAST
Source text for Eikon: ID:nGNX3mctWl
Further company coverage: OBIO.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Orchestra Biomed Holdings
See all newsBrief: Orchestra Biomed Announces Pricing Of Public Offering
Orchestra BioMed slides after starting equity offering
Brief: Orchestra Biomed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Orchestra Biomed Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Orchestra BioMed Q2 revenue drops, net loss widens